Lamisil AT 1% Spray – 15ml

Description

Lamisil AT 1% Spray – 15ml

Lamisil AT 1% Spray is an antifungal treatment used to treat athlete’s foot (tinea pedis) and jock itch (tinea cruris). It contains terbinafine, a clinically proven antifungal agent that clears the infection and relieves symptoms such as itching, burning, and scaling.

⸻

How It Works

Terbinafine works by interfering with the production of a substance called ergosterol, which is essential for the growth and survival of the fungal cell membrane. Without ergosterol, the fungal cells break down and die, clearing the infection. This targeted action means it works directly against the fungus without causing unnecessary irritation to the surrounding skin.

⸻

Directions for Use

For adults and children aged 12 and over, apply the spray once daily to the affected and surrounding skin. For athlete’s foot between the toes, apply once daily for 7 days. For athlete’s foot on the sole or sides of the foot, apply once or twice daily for 7 days. Allow the spray to dry before covering with clothing or footwear. Always read the patient information leaflet before use. If you are unsure about the correct dose, speak to your PillSorted pharmacist.

⸻

Active Ingredients

• Terbinafine hydrochloride 10 mg/g (1% w/w)

⸻

Possible Side Effects

• Mild skin irritation or redness at the application site
• Itching or burning sensation at the application site
• Dryness or peeling of the skin
• Allergic skin reactions (rash, hives) — uncommon
• Contact dermatitis — rare

If you experience any serious side effects, stop taking this medicine and seek medical advice immediately.

⸻

Who Should Not Take This Medicine

• People who are allergic to terbinafine or any other ingredient in this product
• Children under 12 years of age
• Do not apply to the eyes, mouth, nose, or other mucous membranes
• Do not use on nail or scalp infections (this product is not licenced for those areas)
• Avoid applying to broken, inflamed, or severely damaged skin unless advised by a doctor

⸻

Interactions

Lamisil AT 1% Spray is applied to the skin, so the risk of significant drug interactions is very low compared to oral terbinafine. However, avoid using other topical products on the same area of skin at the same time unless advised to do so. Tell your PillSorted pharmacist or doctor about all medicines you are currently taking, including herbal remedies and supplements.

⸻

Pregnancy and Breastfeeding

The safety of topical terbinafine during pregnancy and breastfeeding has not been fully established. As a precaution, avoid applying to the breast area if breastfeeding to prevent accidental ingestion by the infant. Speak to your doctor or PillSorted pharmacist before use if you are pregnant, trying to conceive, or breastfeeding.

⸻

Alcohol

There is no known interaction between alcohol and Lamisil AT 1% Spray when used as a topical treatment. This product is applied to the skin and is not taken by mouth, so alcohol consumption is not expected to affect its safety or effectiveness.

⸻

Driving and Operating Machinery

Lamisil AT 1% Spray is a topical treatment applied to the skin and is not known to cause drowsiness or affect concentration. It is considered safe to drive or operate machinery while using this product.

⸻

Storage

Store below 25°C in a dry place, away from direct heat and sunlight. Do not store near open flames or heat sources, as the spray is flammable. Keep out of sight and reach of children. Do not use after the expiry date shown on the packaging.

⸻

Important Information

• This product is a medicine. Speak to your doctor or PillSorted pharmacist before taking this product if you have an underlying medical condition or are taking any other medication or complementary therapy.
• If symptoms worsen or persist, contact your doctor.
• If pregnant, trying to conceive or breastfeeding, seek medical advice before use.
• If you suffer from allergies, confirm suitability with your PillSorted pharmacist before use.
• Store out of sight and reach of children.
• Read the enclosed patient information leaflet carefully before use.
• Contact your GP where appropriate.

⸻

Patient Information Leaflet

For the full Patient Information Leaflet (PIL) for this medicine, visit the electronic Medicines Compendium (EMC). For further information about this medicine, visit NHS.uk.

⸻

This content has been medically reviewed and approved by Zeinab Ardeshir (GPhC 2075730), Superintendent Pharmacist at PillSorted (GPhC-registered online pharmacy 9011258). Last reviewed: February 2026.

Brand	LAMISIL